News and Articles

As a healthcare provider, keeping pace with the latest clinical evidence and technological advancements in diabetes care while managing the realities of daily practice can be a challenge. The Dexcom...

Diabetes Canada’s updated guidelines recommend automated insulin delivery (AID) systems as the new standard of care for all people living with type 1 diabetes (T1D). Endocrinologist Dr. Ilana Halperin offers...

Healthcare providers play a vital role in supporting individuals living with diabetes manage a complex condition. The Canadian Medical Association Journal (CMAJ) recently highlighted five evidence-informed strategies to help tailor...

As of July 31, 2025, Dexcom G7 sensors and receivers will be officially listed under the Ontario Drug Benefit (ODB) program. This milestone expands access to real-time continuous glucose monitoring...

Diabetes Canada's March 2025 Clinical Practice Guidelines now recommend that all individuals living with type 1 diabetes (T1D) should use Automated Insulin Delivery (AID) systems, provided they are willing and...

The government-funded Saskatchewan Extended Benefits and Drug Plan has expanded coverage for real-time continuous glucose monitoring (rtCGM) systems. Newly included are the following groups of people who use insulin: People...